Form 4: Q32 Bio Executive Receives Stock Grant
Insider Transaction (Form 4)
Shelia M. Violette, Chief Scientific Officer of Q32 Bio Inc., received 37,500 shares of common stock on July 16, 2026.
Summary
- Grant/award: acquired 37,500 Common Stock on July 16, 2026; holds 130,569 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Shelia M. Violette — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Grant/award | Common Stock | 37,500 | — | — | 130,569 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Grant/award (37,500 shares) |
Keywords
insider transaction, Form 4, QTTB, Q32 Bio Inc., neutral, Shelia M. Violette
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.